{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-008402","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2025-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.481299+00:00","generated_at":"2026-05-16T19:11:27.861365+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cosmos Health Q3 2025 revenue $17.1M (+38% YoY), record gross margin 15.2%, cash jumps to $4.63M","bullets":["Q3 2025 revenue $17.11M (up 38% YoY); gross profit $2.60M (+116%), gross margin 15.21% (vs 9.72%).","Adjusted EBITDA loss narrowed 74% to ($0.19M); adjusted EPS $(0.02) vs $(0.34) a year ago.","Cash and cash equivalents surged to $4.63M from $0.66M at June 30, 2025.","Secured $300M digital financing facility and commenced Ethereum purchases.","Contract manufacturing agreement for 3M MYCOFAGYL pessaries annually; Sky Premium Life enters Oman."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-008402","json":"https://secwatch.observer/filing/0001477932-25-008402.json","markdown":"https://secwatch.observer/filing/0001477932-25-008402.md","text":"https://secwatch.observer/filing/0001477932-25-008402.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793225008402/0001477932-25-008402-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793225008402/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:11:27.861365+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}